These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 14633197)
1. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model. Tanigawa M; Sawada T J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):436-42. PubMed ID: 14633197 [TBL] [Abstract][Full Text] [Related]
2. Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae. Tanigawa M; Sawada T J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):513-8. PubMed ID: 12485363 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model. Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine. Vanni M; Merenda M; Barigazzi G; Garbarino C; Luppi A; Tognetti R; Intorre L Vet Microbiol; 2012 Apr; 156(1-2):172-7. PubMed ID: 22104584 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 6, serum amyloid A and haptoglobin as markers of treatment efficacy in pigs experimentally infected with Actinobacillus pleuropneumoniae. Hultén C; Johansson E; Fossum C; Wallgren P Vet Microbiol; 2003 Aug; 95(1-2):75-89. PubMed ID: 12860078 [TBL] [Abstract][Full Text] [Related]
6. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine. Sun D; Mi K; Hao H; Xie S; Chen D; Huang L BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661 [TBL] [Abstract][Full Text] [Related]
7. Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model. Wang H; Liao C; Ding K; Zhang L; Wang L BMC Vet Res; 2024 Jun; 20(1):241. PubMed ID: 38831324 [TBL] [Abstract][Full Text] [Related]
8. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media. Dorey L; Hobson S; Lees P Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures. Kim B; Min K; Choi C; Cho WS; Cheon DS; Kwon D; Kim J; Chae C J Vet Med Sci; 2001 Mar; 63(3):341-2. PubMed ID: 11307940 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a single dose versus a divided dose regimen of amoxycillin in treatment of Actinobacillus pleuropneumoniae infection in pigs. Lauritzen B; Lykkesfeldt J; Friis C Res Vet Sci; 2005 Aug; 79(1):61-7. PubMed ID: 15894026 [TBL] [Abstract][Full Text] [Related]
11. Actinobacillus pleuropneumoniae is impaired by the garlic volatile allyl methyl sulfide (AMS) in vitro and in-feed garlic alleviates pleuropneumonia in a pig model. Becker PM; van Wikselaar PG; Mul MF; Pol A; Engel B; Wijdenes JW; van der Peet-Schwering CM; Wisselink HJ; Stockhofe-Zurwieden N Vet Microbiol; 2012 Jan; 154(3-4):316-24. PubMed ID: 21824734 [TBL] [Abstract][Full Text] [Related]
12. Sub-inhibitory concentrations of penicillin G induce biofilm formation by field isolates of Actinobacillus pleuropneumoniae. Hathroubi S; Fontaine-Gosselin SÈ; Tremblay YD; Labrie J; Jacques M Vet Microbiol; 2015 Sep; 179(3-4):277-86. PubMed ID: 26130517 [TBL] [Abstract][Full Text] [Related]
13. Serotypes, antimicrobial susceptibility, and minimal inhibitory concentrations of Actionbacillus pleuropneumoniae isolated from slaughter pigs in Taiwan (2002-2007). Yang CY; Lin CN; Lin CF; Chang TC; Chiou MT J Vet Med Sci; 2011 Feb; 73(2):205-8. PubMed ID: 20948169 [TBL] [Abstract][Full Text] [Related]
14. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia. Asawa T; Kobayashi H; Mitani K; Ito N; Morozumi T J Vet Med Sci; 1995 Aug; 57(4):757-9. PubMed ID: 8519914 [TBL] [Abstract][Full Text] [Related]
15. Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments. Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A Zentralbl Veterinarmed B; 1999 May; 46(4):249-60. PubMed ID: 10379235 [TBL] [Abstract][Full Text] [Related]
16. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens. Dorey L; Lees P BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327 [TBL] [Abstract][Full Text] [Related]
17. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge. Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae. Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826 [TBL] [Abstract][Full Text] [Related]
19. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida? Dorey L; Hobson S; Lees P J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885 [TBL] [Abstract][Full Text] [Related]
20. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293 [No Abstract] [Full Text] [Related] [Next] [New Search]